Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools

KIBBUTZ SHEFAYIM, Israel, Dec. 19, 2019–(BUSINESS WIRE)–Zebra Medical Vision, the deep learning medical imaging analytics company, announces today a global co-development and commercialization agreement with DePuy Synthes* to bring Artificial Intelligence (AI) opportunities to orthopaedics, based on imaging data.

Every year, millions of orthopaedic procedures worldwide use traditional two-dimensional (2D) CT scans or MRI imaging to assist with pre-operative planning. CT scans and MRI imaging can be expensive, and CT scans are associated with more radiation and are uncomfortable for some patients. Zebra-Med’s technology uses algorithms to create three-dimensional (3D) models from X-ray images. This technology aims to bring affordable pre-operative surgical planning to surgeons worldwide without the need for traditional MRI or CT-based imaging.

“We are thrilled to start this collaboration and have the opportunity to impact and improve orthopaedic procedures and outcomes in areas including the knee, hip, shoulder, trauma, and spine care,” says Eyal Gura, Co-Founder and CEO of Zebra Medical Vision. “We share a common vision surrounding the impact we can have on patients’ lives through the use of AI, and we are happy to initiate such a meaningful strategic partnership, leveraging the tools and knowledge we have built around bone health AI in the last five years.”

This technology is planned to be introduced as part of DePuy Synthes’ VELYS Digital Surgery solutions for pre-operative, operative, and post-operative patient care.

Read more on Zebra-Med’s blog: https://zebramedblog.wordpress.com/another-dimension-to-zebras-ai-how-we-impact-the-orthopedic-world

About Zebra Medical Vision

Zebra Medical Vision’s imaging analytics platform allows healthcare institutions to identify patients at risk of disease and offer improved, preventative treatment pathways, to improve patient care. The company is funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Dolby Ventures. Zebra Medical Vision has raised $52 million in funding to date, and was named a Fast Company Top-5 AI and Machine Learning company. Zebra-Med is a global leader in AI FDA cleared products, and is installed in hospitals globally, from Australia to India, Europe to the U.S, and the LATAM region.

*Agreement is between DePuy Ireland Unlimited Company and Zebra Medical Vision.

Contacts:

Alona Stein for Zebra Medical Vision
alona@blonde20.com

About Peter Coffaro 487 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 25 years of progressive management success within the medical device industry. Recognized by the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager, Distributor, and Vice President. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy, and Stryker. He is also the founder of OrthoFeed: a popular blog that covers digital orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing, and professional education. Peter holds a B.S. degree in Biology and Chemistry from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.